C. Ola Landgren, MD (IMAGE)

University of Miami Miller School of Medicine

C. Ola Landgren, MD

Caption

“There are many new drugs on the horizon for multiple myeloma. It’s an exciting time,” said Dr. C. Ola Landgren, director of the Sylvester Myeloma Research Institute at Sylvester Comprehensive Cancer Center. And now, physicians will learn a lot sooner how well these treatments work.

Credit

Photo by Sylvester Cancer

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.